Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease.
Anandamide (AEA) is the prominent member of the endocannabinoid family and its biological action is mediated through the binding to both type-1 (CB1) and type-2 (CB2) cannabinoid receptors (CBR). The presence of AEA and CBR in the gastrointestinal tract highlighted their pathophysiological role in s...
Guardado en:
Autores principales: | Natalia Battista, Antonio Di Sabatino, Monia Di Tommaso, Paolo Biancheri, Cinzia Rapino, Paolo Giuffrida, Cinzia Papadia, Chiara Montana, Alessandra Pasini, Alessandro Vanoli, Francesco Lanzarotto, Vincenzo Villanacci, Gino R Corazza, Mauro Maccarrone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/996dc2913ad448be9a40d5f92ea22f04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Ayat Zagzoog, et al.
Publicado: (2021) -
Excitability of the motor cortex in de novo patients with celiac disease.
por: Giovanni Pennisi, et al.
Publicado: (2014) -
Anorexia nervosa of the restrictive type and celiac disease in adolescence
por: Nacinovich R, et al.
Publicado: (2017) -
Prevalence of Celiac Disease in Type 1 Diabetic Children and adolescents in East Azarbaijan
por: R Ghergherehchi,, et al.
Publicado: (2010) -
Celiac crisis in patients with celiac disease. Case report
por: Aleksandra V. Babanova, et al.
Publicado: (2021)